EUVIMEDEUVIMED entdecken
Crossref

Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed

Claudia Rossig iD, Andrew D Pearson iD, Gilles Vassal iD, Nicole Scobie iD, Nick Bird iD, Patricia Blanc iD, H Josef Vormoor iD, Friso G Calkoen, Franco Locatelli iD, Francesca Del Bufalo iD, Susana Rives iD, Elad Jacoby iD und 3 weitere

Journal of Clinical Oncology · 2024

DOI: 10.1200/jco.23.01314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Claudia Rossig und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ZORA (Zurich Open Repository and Archive) provides open and worldwide access to the research and scholarly output of the University of Zurich, Switzerland. A focus is on qualified scientific publications. ZORA is operated by the University Library together with the Central IT of the University of Zurich.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenNeoplasmsChildHumansReceptors, Antigen, T-CellT-LymphocytesImmunotherapy, Adoptive

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • ACCELERATE, Brussels, Belgium.
  • Department of Paediatric and Adolescent Oncology, Institut Gustave Roussy and Paris-Saclay University, Villejuif, France.
  • Zoe4Life, Sullens, Switzerland.
  • Solving Kids' Cancer UK, London, United Kingdom.

ORCID-Profile: Claudia Rossig, Andrew D Pearson, Gilles Vassal, Nicole Scobie, Nick Bird, Patricia Blanc, H Josef Vormoor, Franco Locatelli, Francesca Del Bufalo, Susana Rives, Elad Jacoby, Adriana Balduzzi, Jean-Pierre Bourquin, André Baruchel

Zitieren

APA

Rossig, C., Pearson, A. D., Vassal, G., Scobie, N., Bird, N., Blanc, P., Vormoor, H. J., Calkoen, F. G., Locatelli, F., Del Bufalo, F., Rives, S., Jacoby, E., Balduzzi, A., Bourquin, J. P., & Baruchel, A. (2024). Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.01314

Vancouver

Rossig C, Pearson AD, Vassal G, Scobie N, Bird N, Blanc P, et al. Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed. Journal of Clinical Oncology. 2024. doi:10.1200/jco.23.01314

BibTeX
@article{Rossig2024,
  author = {Rossig, Claudia and Pearson, Andrew D and Vassal, Gilles and Scobie, Nicole and Bird, Nick and Blanc, Patricia and Vormoor, H Josef and Calkoen, Friso G and Locatelli, Franco and Del Bufalo, Francesca and Rives, Susana and Jacoby, Elad and Balduzzi, Adriana and Bourquin, Jean-Pierre and Baruchel, André},
  title = {Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/jco.23.01314}
}
Kostenlos starten →